{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T05:11:25Z","timestamp":1788757885204,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    The debate between post-treatment Lyme disease syndrome (PTLDS) and chronic Lyme disease (CLD) reflects different views about the causes and treatment of persistent symptoms attributed to Lyme disease, including symptoms that continue after recommended antibiotic treatment. This study examines how competing positions in the controversy draw on different scientific evidence domains, and how findings from those domains are extended into broader clinical and mechanistic claims. We analysed a 2000\u20132024 literature corpus using a prompt-optimised three-model large language model ensemble to classify abstracts by stance, theme and model-derived study design. We then conducted targeted full-text audits of selected retreatment and treatment-duration trials, and preclinical persistence studies. Across the higher-volume evidence domains, model-derived claim orientations differed by study-design tier. Observational studies and commentaries showed PTLDS-oriented distributions, whereas case reports or series, animal models, and\n                    <jats:italic>in vitro<\/jats:italic>\n                    studies showed CLD-oriented distributions. The smaller RCT and guideline tiers were also PTLDS-oriented, but the small numbers and wide confidence intervals made this direction uncertain. The clinical trial audit showed that some trials reported short-term or symptom-specific improvements, while the interpretation of these findings depended on their durability, endpoint consistency, eligibility criteria, treatment burden, and safety. The citation-conditioned preclinical audit identified findings that support several candidate mechanisms and generate hypotheses for further study, but these findings did not by themselves establish viable infection as the cause of persistent human symptoms or demonstrate the efficacy of prolonged antimicrobial treatment. The findings show a recurring distinction between mechanism-level evidence and the evidence needed to establish patient-level causation or durable clinical benefit. They map how these different forms of evidence are distributed and translated across the PTLDS\u2013CLD literature.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1913455","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:22:57Z","timestamp":1788754977000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence-domain translation in the Lyme disease controversy over persistent post-treatment symptoms"],"prefix":"10.3389","volume":"16","author":[{"given":"Teo","family":"Susnjak","sequence":"first","affiliation":[{"name":"School of Mathematical and Computational Sciences, College of Sciences, Massey University","place":["Auckland, New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Brehme","sequence":"additional","affiliation":[{"name":"University of Innsbruck, Department of Computer Science","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Garg","sequence":"additional","affiliation":[{"name":"Tezted Oy","place":["Jyv\u00e4skyl\u00e4, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Avramovic","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Mater Misericordiae University Hospital","place":["Dublin, Ireland"]},{"name":"School of Medicine, University College Dublin","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Tezted Oy","place":["Jyv\u00e4skyl\u00e4, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCWHITEPAPERMACHINE","volume-title":"Machine learning tools to (semi-)automate evidence synthesis: A rapid review and evidence map 2025 review update Tech. Rep. 25-EHC038","author":"Adam","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1183344","article-title":"Lyme disease and the pursuit of a clinical cure","volume":"10","author":"Adkison","year":"2023","journal-title":"Front. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.48550\/arXiv.2507.19457","article-title":"Gepa: Reflective prompt evolution can outperform reinforcement learning","volume":"131","author":"Agrawal","year":"2025","journal-title":"Arxiv Preprint"},{"key":"B4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/CVI.00071-16","article-title":"Ccl19 as a chemokine risk factor for posttreatment lyme disease syndrome: A prospective clinical cohort study","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1093\/infdis\/jiae203","article-title":"Persistent symptoms after lyme disease: The role of the immune system","volume":"230","author":"Baarsma","year":"2024","journal-title":"J. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1176\/appi.neuropsych.12090223","article-title":"Post-treatment lyme syndrome and central sensitization","volume":"25","author":"Batheja","year":"2013","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/nejmoa1505425","article-title":"Randomized trial of longer-term therapy for symptoms attributed to lyme disease","volume":"374","author":"Berende","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","article-title":"Evidence assessments and guideline recommendations in lyme disease: The clinical management of known tick bites, erythema migrans rashes and persistent disease","volume":"12","author":"Cameron","year":"2014","journal-title":"Expert Rev. Anti-Infective Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/ANNALS-24-02189","article-title":"Development of prompt templates for large language model-driven screening in systematic reviews","volume":"178","author":"Cao","year":"2025","journal-title":"Ann. Internal Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A comparison of two treatment regimens of ceftriaxone in late lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wiener Klinische Wochenschrift"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cct.2012.08.009","article-title":"Antibiotic retreatment of lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials","volume":"33","author":"DeLong","year":"2012","journal-title":"Contemp. Clin. Trials"},{"key":"B12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13643-024-02575-4","article-title":"Title and abstract screening for literature reviews using large language models: An exploratory study in the biomedical domain","volume":"13","author":"Dennst\u00e4dt","year":"2024","journal-title":"Systematic Rev."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16293","article-title":"Treatment of post-treatment lyme disease symptoms\u2014a systematic review","volume":"31","author":"Dersch","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.wnl.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated iv antibiotic therapy for lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \u201cchronic lyme disease\u201d","volume":"357","author":"Feder","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305016120","article-title":"Chatgpt outperforms crowd workers for text-annotation tasks","volume":"120","author":"Gilardi","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1607619","article-title":"Aberrant t-cell phenotypes in a cohort of patients with post-treatment lyme disease","volume":"16","author":"Girgis","year":"2025","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1129","article-title":"On the use of computer-assistance to facilitate systematic mapping","volume":"16","author":"Haddaway","year":"2020","journal-title":"Campbell Syst. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/003591576505800503","article-title":"The environment and disease: Association or causation","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2310.03714","article-title":"Dspy: Compiling declarative language model calls into self-improving pipelines","author":"Khattab","year":"2023","journal-title":"arXiv preprint arXiv:2310.03714"},{"key":"B22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.amjmed.2013.02.014","article-title":"Treatment trials for post-lyme disease symptoms revisited","volume":"126","author":"Klempner","year":"2013","journal-title":"Am. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.wnl.0000071227.23769.9e","article-title":"Study and treatment of post lyme disease (stop-ld) a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the infectious diseases society of america (idsa), american academy of neurology (aan), and american college of rheumatology (acr): 2020 guidelines for the prevention, diagnosis and treatment of lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/cid\/cit939","article-title":"Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study","volume":"58","author":"Marques","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.idc.2022.04.004","article-title":"Persistent symptoms after treatment of lyme disease","volume":"36","author":"Marques","year":"2022","journal-title":"Infect. Dis. Clinics North. America"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciag031","article-title":"Xenodiagnosis to search for Borrelia burgdorferi after antibiotic treatment of lyme disease: A prospective cohort study","author":"Marques","year":"2026","journal-title":"Clin. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr2955","article-title":"The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness","volume":"17","author":"McClune","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1017\/rsm.2025.10014","article-title":"Optimal large language models to screen citations for systematic reviews","volume":"16","author":"Oami","year":"2025","journal-title":"Res. Synth. Methods"},{"key":"B31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical study","volume":"26","author":"Oksi","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B32","first-page":"9340","article-title":"Optimizing instructions and demonstrations for multi-stage language model programs","author":"Opsahl-Ong","year":"2024"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00057","article-title":"Post-treatment lyme disease as a model for persistent symptoms in lyme disease","volume":"7","author":"Rebman","year":"2020","journal-title":"Front. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cTo whom do the results of this trial apply","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-026-05681-3","article-title":"Large language models for scientometric mapping of scientific controversy: A validated hybrid ai\u2013human framework","volume":"131","author":"Susnjak","year":"2026","journal-title":"Scientometrics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100142","article-title":"Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study","volume":"6","author":"Ursinus","year":"2021","journal-title":"Lancet Regional Health \u2013 Europe"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1913455\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:22:58Z","timestamp":1788754978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1913455\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":36,"alternative-id":["10.3389\/fcimb.2026.1913455"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1913455","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1913455"}}